Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) EPS (Basic): 2010-2025

Historic EPS (Basic) for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -$0.16.

  • ProPhase Labs' EPS (Basic) rose 54.29% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.99, marking a year-over-year decrease of 28.39%. This contributed to the annual value of -$2.61 for FY2024, which is 166.33% down from last year.
  • Per ProPhase Labs' latest filing, its EPS (Basic) stood at -$0.16 for Q3 2025, which was down 45.45% from -$0.11 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' EPS (Basic) ranged from a high of $0.81 in Q1 2022 and a low of -$1.59 during Q4 2024.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.30 (2023), whereas its average is -$0.36.
  • Its EPS (Basic) has fluctuated over the past 5 years, first spiked by 1,057.14% in 2022, then crashed by 1,300.00% in 2024.
  • ProPhase Labs' EPS (Basic) (Quarterly) stood at $0.70 in 2021, then slumped by 122.86% to -$0.16 in 2022, then crashed by 218.75% to -$0.51 in 2023, then plummeted by 211.76% to -$1.59 in 2024, then soared by 54.29% to -$0.16 in 2025.
  • Its EPS (Basic) stands at -$0.16 for Q3 2025, versus -$0.11 for Q2 2025 and -$0.13 for Q1 2025.